|
GTX01509
|
GeneTex International Corporation
|
Peanut Lectin (PE)
|
|
FACS, ICC/IF
|
|
|
GTX30957
|
GeneTex International Corporation
|
Protein A (PE)
|
|
FACS, ICC/IF
|
|
|
HY-103660-10mg
|
MedChemexpress LLC
|
18:0 LYSO-PE [CAS 69747-55-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103660-5mg
|
MedChemexpress LLC
|
18:0 LYSO-PE [CAS 69747-55-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112530-100mg
|
MedChemexpress LLC
|
1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine [CAS 1069-79-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-112530-500mg
|
MedChemexpress LLC
|
1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine [CAS 1069-79-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-113951-1mg
|
MedChemexpress LLC
|
Prolyl Endopeptidase Inhibitor 1 [CAS 86925-97-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113951-10mg
|
MedChemexpress LLC
|
Prolyl Endopeptidase Inhibitor 1 [CAS 86925-97-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113951-25mg
|
MedChemexpress LLC
|
Prolyl Endopeptidase Inhibitor 1 [CAS 86925-97-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113951-5mg
|
MedChemexpress LLC
|
Prolyl Endopeptidase Inhibitor 1 [CAS 86925-97-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13682-1mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13682-10mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13682-5mg
|
MedChemexpress LLC
|
MifaMu rtide [CAS 83461-56-7]
|
|
Cancer-programmed cell death
|
|
|
HY-13682B-1mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-10mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-5mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-143671S-25ug
|
MedChemexpress LLC
|
1-Stearoyl-2-arachidonoyl-sn-glycero-3-PE-d11 [CAS 2750554-96-0]
|
|
|
|
|
HY-144006-25mg
|
MedChemexpress LLC
|
14:0 PEG2000 PE [CAS 474922-82-2]
|
|
|
|
|
HY-144006-50mg
|
MedChemexpress LLC
|
14:0 PEG2000 PE [CAS 474922-82-2]
|
|
|
|
|
HY-144012-10mg
|
MedChemexpress LLC
|
16:0 PEG2000 PE [CAS 474922-84-4]
|
|
|
|
|
HY-144012-5mg
|
MedChemexpress LLC
|
16:0 PEG2000 PE [CAS 474922-84-4]
|
|
|
|
|
HY-14672-1mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-10mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-25mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-5mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
